Home » Newsletters » BioWorld

BioWorld

Dec. 4, 1991

View Archived Issues

BLOCKED RICIN TARGETS CANCER

MEDIMMUNE, MERCK COMPLETE DEAL

GENENTECH LICENSES CAMBRIDGE'S HIV PROTEIN

CAL BIO TO TAKE $6 MILLION CHARGE

ITALY APPROVES BTGC's GROWTH HORMONE

GENSIA SUBSIDIARY GETS TWO ANDAs

IVAX RAISES $110.5 MILLION IN PRIVATE OFFERING

FIELD STUDY GUIDELINES DUE

MARKER GENE REMOVED FROM ALTERED PLANTS

NICOTINE PATCH BATTLE HEATS UP

COURT DEALS SETBACK TO KODAK ON PCR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...